HomeNewsOpinionA shift from ABCD to 3Ts may solve Kerala’s COVID-19 puzzle

A shift from ABCD to 3Ts may solve Kerala’s COVID-19 puzzle

Kerala can't afford to remain locked down for months on end, a move that can devastate the local economy and livelihoods. The containment strategy should decisively shift towards 3Ts — Test, Trace, Treat — from the current ABCD approach of community surveillance

August 06, 2021 / 09:20 IST
Story continues below Advertisement

As of 8 am, August 5, there were 411,076 active COVID-19 cases in India. About 43 percent or 176,654 of this were in Kerala, effectively implying that more than four out of every 10 active COVID-19 cases in India were from just one state.

In the last 24 hours (until 8 am, August 5), India reported a total of 42,982 new COVID-19 cases. More than half (52 percent) or 22,414 cases were recorded in Kerala.

Story continues below Advertisement

This has been a worryingly persistent trend over the last few weeks. During the seven days from July 28 to August 3, Kerala has accounted for half of the country’s total COVID-19 cases.

These numbers present a paradox of sorts. Why has Kerala, the only Indian state equipped with world class health infrastructure, a high per capita availability of health workers, an efficient public health administration, and relatively greater health awareness among people, has remained an contrarian outlier in COVID-19 management?

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show